Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends



Rating:

Share or cite this content

Citations should be made in the following way:
A. Stainer (Monza, Italy), P. Faverio (Monza, Italy), S. Busnelli (Monza, Italy), F. Luppi (Monza, Italy), A. Monzani (Monza, Italy), F. Ammatuna (Monza, Italy), F. Montanelli (Monza, Italy), M. Catalano (Monza, Italy), L. Parachini (Monza, Italy), S. Zucchetti (Garbagnate Milanese, Italy), A. Pesci (Monza, Italy). Pulmonary sequelae in patients with COVID-19: results after 3 months of follow-up. 2535

Member's Comments

No comment yet.

Related content which might interest you: Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases Year: 2017 One year follow-up on pulmonary function for lobectomized patients. Source: International Congress 2017 – General thoracic surgery Year: 2017 Advanced pulmonary sarcoidosis: long-term follow-up of 10 years or more. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 COVID-19: Is pulmonary damage present after 10 weeks follow-up? Source: Virtual Congress 2021 – Chronic COVID - 19 Year: 2021 Pulmonary function and tomographic features of COVID-19 survivors 2 months after hospital discharge: a cohort study Source: Virtual Congress 2021 – Long COVID - 19 Year: 2021 Five years follow-up after pulmonary rehabilitation of patients with COPD Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes Year: 2010 Mortality and recurrence during a follow-up of 2 years of pulmonary embolism: Role of anticoagulant therapy Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Optimizing treatment for life-threatening hemoptysis: a prospective follow-up of 101 patients over 1 year Source: Eur Respir J 2007; 30: Suppl. 51, 559s Year: 2007 Long-term follow-up of patients with pulmonary sarcoidosis Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Evolution of pulmonary embolism: 1 year of follow-up Source: Eur Respir J 2006; 28: Suppl. 50, 401s Year: 2006 The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up) Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Predicting factors of pulmonary functional sequelae in COVID-19 patients after 4 months from hospital admission Source: Virtual Congress 2021 – Long COVID - 19 Year: 2021 Long-term predictors of lung function decrease in asthmatics: a 9 year follow-up study Source: Eur Respir J 2006; 28: Suppl. 50, 145s Year: 2006 Predictors of benefit persistence after 6 months from a pulmonary rehabilitation programme in moderate-severe COPD patients Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 Are the benefits of pulmonary rehabilitation sustained after 6 months? Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation Year: 2011 Effect of bariatric surgery on asthma: 3 months follow-up Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012 A seven week out patient pulmonary rehabilitation programme versus a four week out patient pulmonary rehabilitation programme: results at six months Source: Eur Respir J 2005; 26: Suppl. 49, 68s Year: 2005 1 year clinical follow-up of patients affected by acute pulmonary embolism (PE) Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005 Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 6 months treatment results of cyclophosphamide+prednisolone in scleroderma patients with lung involvement Source: Eur Respir J 2003; 22: Suppl. 45, 47s Year: 2003